kentucky tirzepatide lawsuit CVS Caremark stopped covering a GLP-1 for obesity. Now there's a Ozempic Lawsuit [July 2026 Update]

Insulin use alone does NOT determine Type 1 many T2DM patients require insulin

In practice, this is where patients often need more guidance than they realize

They reference the FDA-approved titration schedule without acknowledging that compounding pharmacies often use different concentrations, different vial sizes, and sometimes different escalation protocols altogether

Novo Nordisk will continue to work with the TGA to provide updates on this matter. What does the TGA advise

The SURMOUNT-4 trial demonstrated that continuing treatment maintains 95% of weight loss while stopping leads to substantial regain for most individuals